Two thousand dollars a month is the number you carry around in your head as the difference between a comfortable retirement and a stressful one. The catch is you want the check to arrive without you slicing off pieces of your nest egg to fund it. Dividend ETFs do exactly that, and four of them keep showing up on serious income portfolios: the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD), the Vanguard High Dividend Yield ETF (NYSEARCA:VYM), the iShares Core Dividend Growth ETF (NYSEARCA:DGRO), and the Vanguard Dividend Appreciation ETF (NYSEARCA:VIG).
Own them in the right mix and $24,000 a year in cash lands in your brokerage account while every share you started with is still sitting there.
The math behind $2,000 a month
Living off dividends means the payout is doing the work, while the share price sits in the background. SCHD alone paid $1.0480 per share over the trailing twelve months. VYM and VIG add yield and dividend growth on top of that. The point of stacking four funds is diversification: you spread your grocery money across multiple methodologies and issuers.
SCHD: the low-cost income engine
Schwab’s flagship dividend fund is where most income investors start, and for good reason. The expense ratio is 0.06%, meaning $9,994 of every $10,000 you invest stays working for you. It runs $71.6 billion in net assets and leans hard into companies that actually cut checks: Bristol-Myers Squibb at 4.26%, Merck at 4.14%, ConocoPhillips at 4.10%, Lockheed Martin at 4.07%, and Chevron at 4.04% anchor the top of the portfolio. Shares closed at $32.24, and the fund is up 19.45% year to date. Quarterly payments in 2026 have run in the $0.25 to $0.28 per share range, so income is predictable enough to budget around.
VYM: the yield-first sibling
Vanguard’s High Dividend Yield ETF casts a wider net, holding 400+ positions and skewing toward the biggest checkbook writers in the S&P universe. Its top position, Broadcom at 8.03%, is followed by financial and energy heavyweights like JPMorgan Chase (3.34%), Exxon Mobil (2.72%), and Johnson & Johnson (2.30%). Shares trade at $160.14 and the fund is up 12.93% YTD, with a 200.54% ten-year total return. VYM’s job in this quartet is breadth. When one sector’s dividends wobble, four hundred other tickers keep the deposits flowing.
DGRO: growth in the payout alongside the price
Yield today is nice. A raise every year is better. iShares Core Dividend Growth screens for companies with a track record of increasing distributions, which is why it has quietly returned 252.84% over ten years and 20.97% over the past year. The expense ratio is 0.08%, and shares sit at $76.91. If SCHD is the paycheck, DGRO is the cost-of-living adjustment.
VIG: the defensive anchor
VIG tracks companies that have raised dividends for at least a decade, and it charges the lowest fee of the group at 0.04%. That is $4 a year on a $10,000 position. Shares closed at $239.03, up 9.63% YTD and 241.62% over ten years. Yields here are modest because the fund tilts toward quality rather than headline payout. Think of VIG as the ballast that keeps the ship steady when energy or pharma dividends have a rough quarter.
The trade-off
Hitting $2,000 a month from these four funds is not free. Current yields imply you need somewhere in the neighborhood of $600,000 to $800,000 invested, depending on your blend, and dividend stocks are still stocks. SCHD’s 19.45% YTD run can reverse in a bad market, and payouts can be cut. The 2024 SCHD distribution schedule looked very different from 2025’s, which is a reminder that quarterly amounts do fluctuate. Spread across all four ETFs, though, no single dividend cut wrecks your monthly budget. You keep every share, the deposits keep landing, and the raises show up over time. That is the deal these four funds actually offer.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks